CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Nov 04, 2024. (Total: 6390 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-9 (of 9 Records)

Query Trace: Willby M[original query]
Expanded geographic distribution for two Legionella pneumophila sequence types of clinical concern Hamlin JAP , Kozak-Muiznieks NA , Mercante JW , Rishishwar L , Norris ET , Gaines AB , Ishaq MK , Winchell JM , Willby MJ . mSphere 2024 e0075623
Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis. Willby M , Chopra P , Lemmer D , Klein K , Dalton TL , Engelthaler DM , Cegielski P , Posey JE . Antimicrob Agents Chemother 2020 65 (1)
Detection of Apparent Cell-free M. tuberculosis DNA from Plasma. Click ES , Murithi W , Ouma GS , McCarthy K , Willby M , Musau S , Alexander H , Pevzner E , Posey J , Cain KP . Sci Rep 2018 8 (1) 645
Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO Genoscholar(™)·PZA-TB II as compared to conventional sequencing. Willby MJ , Wijkander M , Havumaki J , Johnson K , Werngren J , Hoffner S , Denkinger CM , Posey JE . Antimicrob Agents Chemother 2017 62 (1)
Rv3351c, a Mycobacterium tuberculosis gene that affects bacterial growth and alveolar epithelial cell viability. Pavlicek RL , Fine-Coulson K , Gupta T , Quinn FD , Posey JE , Willby M , Castro-Garza J , Karls RK . Can J Microbiol 2015 61 (12) 1-10
Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 µg/ml in MGIT. Whitfield MG , Warren RM , Streicher EM , Sampson SL , Sirgel FA , van Helden PD , Mercante A , Willby M , Hughes K , Birkness K , Morlock G , van Rie A , Posey JE . J Clin Microbiol 2015
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis. Reeves AZ , Campbell PJ , Willby MJ , Posey JE . Antimicrob Agents Chemother 2014 59 (1) 444-9
Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG. Gajadeera C , Willby MJ , Green KD , Shaul P , Fridman M , Garneau-Tsodikova S , Posey JE , Tsodikov OV . J Antibiot (Tokyo) 2014 68 (3) 153-7
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. Malik S , Willby M , Sikes D , Tsodikov OV , Posey JE . PLoS One 2012 7 (6) e39754